Chairman of the ACRF Medial Research Advisory Committee, Professor Ian Frazer, has been appointed a Fellow of the esteemed Royal Society of London for his ground-breaking research that resulted in a vaccine for cervical cancer.
The 350 year old scientific academy acknowledges some of the most distinguished scientists in the world, with current and previous Fellows including Michael Faraday, Stephen Hawking and Isaac Newton.
“Election to The Royal Society is a great and unexpected honor, providing an opportunity to interact with the world’s leading scientists,” Professor Frazer said.
“I’m thrilled that the Institute’s contribution to medical research has been publicly recognised in this manner.”
Professor Frazer’s appointment acknowledges his work in the discovery of the cervical cancer vaccine, which was developed at Queensland’s Diamantina Institute following seed-funding from ACRF. Since its release in 2006, over 40 million doses of this life-saving vaccine have been administered to women and girls in more than 90 countries.
Professor Frazer was named Australian of the Year in 2006 – one of a multitude of prestigious accolades spanning a scientific career of over 30 years.
In 2005 he was appointed to the ACRF Medical Research Advisory Committee and became Chair in 2009. Along with 12 world class scientists, Professor Frazer reviews all applications seeking ACRF funding, and recommends the most promising research projects to receive our support.
The Australian Cancer Research Foundation (ACRF) has provided 41 grants totaling almost $71 million to Australian cancer research institutes since 1987 with over $49 million awarded in the last six years.
Related Posts
